Journal of Parkinsons Disease

Papers
(The H4-Index of Journal of Parkinsons Disease is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Clinical Trial Highlights: Modulators of Mitochondrial Function107
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists97
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?85
One world, one goal: Advocacy and policy for a unified Parkinson's response81
Creation of a machine learning-based model for early identification of mild cognitive impairment risk in Parkinson's disease: A PD research center-based population study75
A prospective analysis of falls in Parkinson's disease: Does physical capacity moderate the relationship between walking amount and falls rates?69
Feasibility and potential effectiveness of an exergame program for people with moderate to advanced Parkinson's disease: A pilot randomized controlled trial65
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease63
When Parkinson's disease interferes in a couple's life: A qualitative study62
Acknowledgment to reviewers 202561
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention57
Impact and management of cognition on speech and swallow function in Parkinson's disease57
Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort55
A framework to standardize gait study protocols in Parkinson's disease51
Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease47
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression46
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease44
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients42
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?41
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”40
The fixel GI Parkinson's research and integrated support model (PRISM)38
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort38
A monoclonal antibody-based immunoassay reinforces DOPA decarboxylase in cerebrospinal fluid as a diagnostic biomarker for Parkinson's disease with potential prognostic value36
Are Preformed Fibrils a Model of Parkinson’s Disease?36
Anxiety is associated with increased risk of suicidality in Parkinson's disease36
Longitudinal change in swallow function in patients with Parkinson's disease (PD)36
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease34
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders34
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease34
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”33
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder32
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis32
What medicines do people with Parkinson's disease want?32
0.15451693534851